Biotechnology·Finance·Investing·News The Astonishing 945% Surge: Is Monopar Therapeutics’ Cash Strategy the Key to Its Success? Monopar Therapeutics experienced a remarkable 945% surge in share price over the past year, attributed to strategic cash management rather than revenue by Marques Jivaro 18 hours ago
Starting Over at 42: How a Single Parent is Turning Financial Angst into a Strategic Opportunity 2 hours ago
A Tumultuous Day in Global Markets: Trump’s Tariff Rollercoaster Sends Shockwaves Worldwide 5 hours ago